Zheshang Securities(601878)
Search documents
浙商证券:维持鱼跃医疗“增持”评级,全年收入利润增长可期
Xin Lang Cai Jing· 2025-09-17 06:20
Core Viewpoint - Yuyue Medical reported a net profit attributable to shareholders of 1.203 billion yuan in the first half of 2025, representing a year-on-year increase of 7.4% [1] - The second quarter net profit reached 578 million yuan, showing a significant year-on-year growth of 25%, indicating a recovery in profit growth on a quarter-on-quarter basis [1] Revenue Growth - The overseas revenue for the first half of 2025 was 607 million yuan, marking a year-on-year increase of 26.6% [1] - The company is expected to see continued revenue and profit growth in 2025, driven by demand recovery and channel expansion in the second half of the year [1] Product Performance - Revenue growth by segment for the first half of 2025 includes: - Respiratory treatment solutions: 1.9% increase - Blood glucose and POCT: 20% increase - Home health testing: 15% increase - Clinical instruments and rehabilitation: 3.3% increase - Emergency segment: 31% increase [1] - The respiratory treatment segment is experiencing a recovery in revenue growth, driven by increased sales of ventilators and overseas expansion [1] Strategic Outlook - The company is currently in a phase of expanding overseas channels and promoting new products, which may lead to sustained sales expense investments in 2025 [1] - However, through cost reduction and efficiency improvements, along with economies of scale, the net profit margin is expected to remain at a high level [1] - The recommendation to maintain an "overweight" rating reflects confidence in the company's growth trajectory [1]
协创数据股价涨5.07%,浙商证券资管旗下1只基金重仓,持有1.46万股浮盈赚取11.64万元
Xin Lang Cai Jing· 2025-09-17 05:29
Group 1 - The core viewpoint of the news is that Xiechuang Data has experienced a significant stock price increase, rising 5.07% on September 17, with a total market capitalization of 57.09 billion yuan and an 8-day cumulative increase of 63.53% [1] - Xiechuang Data, established on November 18, 2005, and listed on July 27, 2020, specializes in the research, production, and sales of IoT smart terminals and data storage devices, continuously adapting to technological changes and market trends [1] - The company's main business revenue composition includes: data storage devices (37.11%), intelligent computing products and services (24.69%), IoT smart terminals (17.70%), server and peripheral remanufacturing (16.88%), and others (3.62%) [1] Group 2 - From the perspective of fund holdings, Zhejiang Merchants Securities Asset Management has a fund that heavily invests in Xiechuang Data, with the fund "Zhejiang Merchants Huijin Transformation Growth" holding 14,600 shares, accounting for 3.23% of the fund's net value [2] - The fund has achieved a year-to-date return of 37.07% and a one-year return of 61.86%, ranking 1869 out of 8172 and 2178 out of 7980 in its category, respectively [2] - The fund manager, Ma Binbo, has been in position for 7 years and 267 days, with the best fund return during his tenure being 78.16% [2]
研报掘金丨浙商证券:维持太辰光“买入”评级,下游持续高景气,业绩延续高增态势
Ge Long Hui A P P· 2025-09-16 09:09
Core Viewpoint - The report from Zheshang Securities highlights that Taicheng Light achieved a net profit attributable to shareholders of 173 million yuan in the first half of the year, representing a year-on-year increase of 118.0% [1] Financial Performance - In Q2 2025, the company realized a net profit of 94 million yuan, which is a year-on-year increase of 96.8% and a quarter-on-quarter increase of 18.4% [1] - The company's external sales revenue reached 681 million yuan in the first half of the year, marking a year-on-year growth of 71.19% [1] Market Demand and Growth Strategy - The explosive growth in global AI computing power demand has significantly boosted the company's demand [1] - The company is actively expanding production capacity through a dual approach of "domestic + overseas" strategies [1] Product Development and Supply Chain - MT insert is the core component of MPO connectors, and the company is focusing on independent research and production of MT inserts through its subsidiary [1] - The self-developed MT insert manufactured MPO connectors have achieved large-scale production and sales in the first half of the year, with ongoing efforts to certify more specifications of MT inserts [1] - The self-sufficiency of core components not only ensures supply chain security but also directly enhances product gross margins [1] Investment Rating - The report maintains a "Buy" rating for the company [1]
研报掘金丨浙商证券:维持开立医疗“增持”评级,Q2收入增速回正,全年增长可期
Ge Long Hui A P P· 2025-09-16 06:48
Core Viewpoint - The report from Zheshang Securities indicates that Kaili Medical's net profit attributable to shareholders for H1 2025 is projected to be 47 million yuan, representing a year-on-year decline of 72.4% [1] Financial Performance - The net profit for Q2 2025 is expected to be 39 million yuan, showing a year-on-year decrease of 44.7% [1] - The impact of domestic medical equipment bidding and procurement in 2024 is anticipated to affect revenue and profit growth in H1 2025 [1] Future Outlook - As the bidding process is expected to gradually recover in 2025, Q2 revenue growth is projected to turn positive year-on-year [1] - The company is expected to see overall revenue growth for the full year of 2025, driven by the recovery of the bidding process [1] Profit Forecast Adjustment - Due to the impact of bulk procurement on gross margins and ongoing expense investments, the profit forecasts for the company from 2025 to 2027 have been revised downward [1] - The rating for the company remains "Buy" despite the adjustments [1]
迈得医疗股价涨5.79%,浙商证券资管旗下1只基金重仓,持有4.3万股浮盈赚取4.86万元
Xin Lang Cai Jing· 2025-09-16 02:16
截至发稿,陈顾君累计任职时间5年241天,现任基金资产总规模2.04亿元,任职期间最佳基金回报 36.87%, 任职期间最差基金回报-7.57%。 数据显示,浙商证券资管旗下1只基金重仓迈得医疗。浙商汇金新兴消费(009527)二季度持有股数4.3 万股,占基金净值比例为2.79%,位居第七大重仓股。根据测算,今日浮盈赚取约4.86万元。 浙商汇金新兴消费(009527)成立日期2020年5月29日,最新规模2273.84万。今年以来收益18.39%,同 类排名4505/8174;近一年收益53.15%,同类排名2837/7982;成立以来收益15.9%。 浙商汇金新兴消费(009527)基金经理为陈顾君。 9月16日,迈得医疗涨5.79%,截至发稿,报20.66元/股,成交5669.63万元,换手率1.69%,总市值34.34 亿元。 资料显示,迈得医疗工业设备股份有限公司位于浙江省玉环市沙门镇滨港工业城,成立日期2003年3月 10日,上市日期2019年12月3日,公司主营业务涉及医用耗材智能装备的研发、生产、销售和服务。主 营业务收入构成为:安全输注类连线机42.18%,血液净化类连线机37.90%,安 ...
专访浙商证券首席经济学家李超:目前是结构性牛市,信息杠杆使投资者入市速率变快
Zheng Quan Shi Bao· 2025-09-15 13:39
Group 1: Economic Trends - The manufacturing investment has maintained a relatively high growth rate, indicating positive changes in economic structure adjustment [1][2] - The current economic state is better described as economic development rather than just economic growth rate, with a focus on transitioning from real estate to manufacturing [2][3] - The August PMI data showed a slight increase of 0.1 percentage points, but it has not fully returned to the expansion zone, highlighting the ongoing economic recovery [2] Group 2: Consumption and Investment - Consumption has consistently outperformed investment in recent years, although there are concerns about the sustainability of this trend due to government policies [2][3] - Real estate and infrastructure investments are relatively weak, while manufacturing investment continues to show strong growth, reflecting structural adjustments [2][3] - The external demand remains strong due to China's competitive export products, which are of good quality and reasonably priced [2] Group 3: Domestic Circulation and Consumer Behavior - Insufficient domestic demand is a significant challenge for economic operation, linked to consumer income and savings behavior [3] - The government has implemented measures to stimulate consumption, such as trade-in policies, and is shifting focus from green initiatives to smart consumption [3] Group 4: Market Dynamics - The current A-share market is characterized as a structural bull market driven primarily by liquidity rather than a broad market rally [6] - Information leverage has accelerated the rate at which investors enter the market, influenced by social interactions and media [6][7] - The phenomenon of retail investors re-engaging in the market indicates a potential shift in market dynamics as the bull market progresses [7]
专访浙商证券首席经济学家李超:信息杠杆之下 金融市场传播速率变快
Sou Hu Cai Jing· 2025-09-15 09:28
Economic Outlook - The manufacturing investment has maintained a relatively high growth rate in recent years, indicating positive changes in economic structure [1][2] - The current economic state is better described as economic development rather than just economic growth rate, with a focus on transitioning from real estate to manufacturing [2][3] Market Analysis - The A-share market is characterized as a structural bull market rather than a comprehensive bull market, primarily driven by liquidity [1][6] - There is a notable absence of large-scale movement of household savings into the stock market, with professional investors and margin financing being the main sources of liquidity [6][7] Consumer Behavior - Consumer spending is closely related to income, with excess savings being a significant issue due to a lack of attractive investment opportunities and declining income expectations [3] - Government policies, such as trade-in programs, are aimed at stimulating consumption and guiding consumer behavior towards more positive changes [3] New Economic Drivers - The transition from old to new economic drivers is underway, with innovative companies emerging as a signal of potential in high-tech industries [4] - The market is witnessing a shift in focus from traditional industries to sectors that align with future economic development [4] Information Leverage - The concept of information leverage is highlighted, where the speed of information dissemination influences investor behavior and accelerates market entry [2][6][7] - The phenomenon of retail investors re-engaging in the market is observed, indicating a shift in market dynamics as information spreads rapidly through social networks [7]
舒泰神股价跌5.02%,浙商证券资管旗下1只基金重仓,持有14.39万股浮亏损失29.21万元
Xin Lang Cai Jing· 2025-09-15 06:45
Core Viewpoint - Shuyou Shen (Beijing) Biopharmaceutical Co., Ltd. experienced a 5.02% drop in stock price, closing at 38.43 CNY per share, with a trading volume of 1.195 billion CNY and a turnover rate of 6.71%, resulting in a total market capitalization of 18.361 billion CNY [1] Company Overview - Shuyou Shen was established on August 16, 2002, and went public on April 15, 2011. The company is primarily engaged in the research, development, production, and sales of biological products and some chemical drugs [1] - The main revenue sources are: 59.17% from injectable mouse nerve growth factor (Sutai Sheng), 33.19% from compound polyethylene glycol electrolyte powder, and 7.63% from other products [1] Fund Holdings - Zhejiang Merchants Securities Asset Management has a fund that heavily invests in Shuyou Shen. The fund, Zhejiang Merchants Huijin Quantitative Selected Mixed Fund (006449), held 143,900 shares in the second quarter, accounting for 5.18% of the fund's net value, making it the second-largest holding [2] - The fund has a current scale of 104 million CNY and has achieved a return of 65.21% this year, ranking 376 out of 8,246 in its category. Over the past year, it has returned 95.51%, ranking 580 out of 8,054 [2] Fund Manager Information - The fund manager of Zhejiang Merchants Huijin Quantitative Selected Mixed Fund is Pang Yaqing, who has been in the position for 1 year and 231 days. The fund's total asset size is 104 million CNY, with the best and worst returns during the tenure both recorded at 75.13% [3]
圣邦股份股价涨20%,浙商证券资管旗下1只基金重仓,持有6000股浮盈赚取8.74万元
Xin Lang Cai Jing· 2025-09-15 01:57
浙商鼎盈事件驱动混合(LOF)(169201)基金经理为张雷。 截至发稿,张雷累计任职时间186天,现任基金资产总规模983.57万元,任职期间最佳基金回报 11.93%, 任职期间最差基金回报11.93%。 风险提示:市场有风险,投资需谨慎。本文为AI大模型自动发布,任何在本文出现的信息(包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等)均只作为参考,不构成个人投资建 议。 从基金十大重仓股角度 数据显示,浙商证券资管旗下1只基金重仓圣邦股份。浙商鼎盈事件驱动混合(LOF)(169201)二季度 持有股数6000股,占基金净值比例为4.44%,位居第六大重仓股。根据测算,今日浮盈赚取约8.74万 元。 浙商鼎盈事件驱动混合(LOF)(169201)成立日期2016年12月7日,最新规模983.6万。今年以来收益 20%,同类排名4209/8246;近一年收益43.22%,同类排名3801/8054;成立以来收益67.91%。 责任编辑:小浪快报 9月15日,圣邦股份涨20%,截至发稿,报87.42元/股,成交30.11亿元,换手率5.84%,总市值540.27亿 元。 资料显示,圣邦微电子 ...
浙商证券:VLCC运价屡创新高 Q4油运旺季可期
智通财经网· 2025-09-14 11:35
Core Viewpoint - VLCC TD3C freight rates reached $74,338 per day on September 11, marking a 113% year-on-year increase, surpassing Q4 data for 2023 and 2024, indicating potential for record high rates in Q4 2023 [1][2] Supply and Demand Dynamics - OPEC+ has been a key demand catalyst, announcing an increase of 137,000 barrels per day in October, with cumulative increases of 2.193 million barrels per day since March [3] - Continuous sanctions from the US and EU on Russian and Iranian fleets have tightened supply, with 1,636 vessels sanctioned globally, accounting for 4% of total capacity, including 830 oil tankers [4] VLCC Supply Constraints - Only 3 VLCCs have been delivered this year, with 1 vessel scrapped, leading to a tight supply situation; the current VLCC fleet consists of 906 vessels, with 20.2% over 20 years old [5] - The order book shows 112 VLCCs, with limited deliveries expected before mid-2026, maintaining a tight supply environment [5] Investment Recommendations - The expanding supply-demand gap suggests that freight rates may reach new highs this year, with continued recommendations for companies such as China Merchants Energy Shipping (601872.SH), COSCO Shipping Energy Transportation (600026.SH), and China Merchants Jinling Shipyard (601975.SH) [6]